Use of antidepressants in the treatment of negative symptoms of schizophrenia

L'Encéphale
A PalombaJ-M Azorin

Abstract

Negative symptoms account for a clinical dimension of schizophrenia. They are partly the cause of functional disability of this disease. Clinical experience shows that antipsychotics have little or no effect on these symptoms. The aim of this review is to gather existing data on the treatment of negative symptoms with antidepressants. The combination of antipsychotics with antidepressants is a therapeutic strategy commonly used for the treatment of these symptoms. The pro-dopaminergic effects of antidepressants explain their effectiveness on negative symptoms. There are many comparative, randomized, controlled studies evaluating the efficacy of antidepressant associated with antipsychotic for the treatment of negative symptoms. Furthermore three meta-analyses have been conducted. The overall results suggest that the use of antidepressants may contribute to clinical improvement of negative symptoms in schizophrenia. The limitations of these studies are the small number of patients included and the definition and assessment of negative symptoms. The existing scales are not sufficiently discriminating. Further research using new measurement tools should help refine these results.

References

Nov 1, 1989·Psychiatry Research·B KirkpatrickW T Carpenter
Feb 1, 1987·The Journal of Nervous and Mental Disease·E S ProsserL E Hollister
May 1, 1988·The American Journal of Psychiatry·W T CarpenterA M Wagman
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 12, 1980·British Medical Journal·T J Crow
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen, S Olsen
Oct 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·A V Mackay
Jan 1, 1994·International Clinical Psychopharmacology·E SpinaA P Caputi
Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·N C AndreasenM Flaum
Jun 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·D A KibelP F Liddle
Dec 17, 2004·International Clinical Psychopharmacology·M C Jockers-ScherüblP Schlattmann
Nov 12, 2005·European Journal of Clinical Pharmacology·E AcquavivaB Falissard
Feb 17, 2006·Schizophrenia Bulletin·Brian KirkpatrickStephen R Marder
Mar 6, 2007·Schizophrenia Research·Marc De HertJoseph Peuskens
Sep 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Surendra P SinghKelvin Chan
Jul 17, 2013·Journal of Clinical Psychopharmacology·Kim HinkelmannThomas J Raedler
Sep 14, 2013·Schizophrenia Research·Stephen R MarderJonathan Rabinowitz
Nov 21, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Michael C DavisStephen R Marder
Nov 30, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Joanna C NeillDominic M Dwyer
Jul 9, 2014·The Journal of Clinical Psychiatry·Judith UsallUNKNOWN Abordaje Síntomas Negativos Esquizofrenia Group

❮ Previous
Next ❯

Citations

Nov 10, 2020·Psychotherapy and Psychosomatics·Steven L DubovskyVictoria Cranwell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here